United Health Products Files 8-K: Material Agreement & Equity Sales

TL;DR

UNHP inks new deal, issues stock. Watch closely.

AI Summary

On December 16, 2025, United Health Products, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also reported unregistered sales of equity securities. The filing includes financial statements and exhibits.

Why It Matters

This filing indicates significant corporate activity, including new financial obligations and equity transactions, which could impact the company's financial structure and shareholder value.

Risk Assessment

Risk Level: medium — The filing details a material definitive agreement and unregistered equity sales, which can introduce financial obligations and dilutive effects.

Key Players & Entities

• United Health Products, Inc. (company) — Registrant
• December 16, 2025 (date) — Date of earliest event reported
• Nevada (jurisdiction) — State of incorporation
• 000-27781 (identifier) — SEC File Number
• 84-1517723 (identifier) — EIN

FAQ

Key Financial Figures

• $289,821 — missory note in the principal amount of $289,821 (the "Note"). The Company received net
• $250,000 — ). The Company received net proceeds of $250,000 at closing. Pursuant to the terms of th
• $0.06 — common stock at the Conversion Price of $0.06 per share (subject to certain adjustmen
• $4,000,000 — ated to purchase, up to an aggregate of $4,000,000 (the "Commitment Amount") of shares of
• $0.075 — 's common stock at a price per share of $0.075 per share, subject to certain adjustmen

Filing Documents

• ueec_8k.htm (8-K) — 36KB
• ueec_ex41.htm (EX-4.1) — 231KB
• ueec_ex42.htm (EX-4.2) — 121KB
• ueec_ex101.htm (EX-10.1) — 204KB
• ueec_ex102.htm (EX-10.2) — 158KB
• ueec_ex103.htm (EX-10.3) — 184KB
• 0001477932-25-009157.txt ( ) — 1254KB
• ueec-20251216.xsd (EX-101.SCH) — 5KB
• ueec-20251216_lab.xml (EX-101.LAB) — 13KB
• ueec-20251216_cal.xml (EX-101.CAL) — 1KB
• ueec-20251216_pre.xml (EX-101.PRE) — 8KB
• ueec-20251216_def.xml (EX-101.DEF) — 2KB
• ueec_8k_htm.xml (XML) — 3KB

01

Item 1.01. Entry into a Material Definitive Agreement. Securities Purchase Agreement – Note and Registration Rights Agreement On December 16, 2025, United Health Products, Inc. (the "Company") entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with Alumni Capital LP, a Delaware limited partnership ("Alumni"), pursuant to which Alumni made a loan to the Company, evidenced by a senior convertible promissory note in the principal amount of $289,821 (the "Note"). The Company received net proceeds of $250,000 at closing. Pursuant to the terms of the Note, all accrued and unpaid interest at the rate of 15% per annum and any outstanding principal, subject to adjustment, is required to be paid on or before December 31, 2026. The Note is offered in reliance on Section 4(a)(2) of Securities Act of 1933, as amended (the "Securities Act") and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable. Upon the occurrence and during the continuation of any Event of Default (as defined in the Note), the Note shall become immediately due and payable and the Company will be obligated to pay to Alumni, in full satisfaction of its obligations, an amount equal to the then outstanding principal amount of the Note, plus accrued and unpaid default interest, if any. Furthermore, Alumni may convert the outstanding unpaid principal amount of the Note (along with any interest, penalties, and all other amounts owed under the Note) into restricted shares (the "Conversion Shares") of the Company's common stock at the Conversion Price of $0.06 per share (subject to certain adjustments upon an Event of Default or otherwise as set forth in the Note). Pursuant to the terms of the Note, Alumni has agreed to limit the amount of co

03

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained above in Item 1.01 is hereby incorporated by reference into this Item 2.03.

02

Item 3.02. Unregistered Sales of Equity Securities. The information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02.

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibit No. Description 4.1 Convertible Promissory Note, dated December 16, 2025, by and between Company and Alumni Capital LP 4.2 Form of Common Stock Purchase Warrant, dated December 16, 2025 10.1 Securities Purchase Agreement, dated December 16, 2025, by and between the Company and Alumni Capital LP 10.2 Registration Rights Agreement, dated December 16, 2025, by and between Company and Alumni Capital LP 10.3 Any Market Purchase Agreement, dated December 16, 2025, by and between Company and Alumni Capital LP 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. United Health Products, Inc. Dated: December 22, 2025 By: /s/ Brian Thom Brian Thom Chief Executive Officer 4

View Full Filing

View this 8-K filing on SEC EDGAR